Collateral for a security interest recorded Aug 4, 2022 (Heritage Bank of Commerce).
Term ends Apr 9, 2035 · High confidence
20-year base term ends Apr 9, 2035
Held by Vivex Biologics Group, Inc.
Filed Dec 11, 2017 as application 15/837,694 · Granted Nov 2, 2021
Base term plus 34 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2015
2035
Clock starts
Apr 9, 2015
Apr 9, 2015
Term ends
Apr 9, 2035
Apr 9, 2035
Granted
Nov 2, 2021
Nov 2, 2021
base term
fee events
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
34
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,513,690, US 10,829,740, US 11,077,147, US 11,471,559, US 9,675,643, US 9,675,644, US 9,687,511.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
12
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 34 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 9, 2015, when application 14/682,523, the earliest non-provisional in its chain, was filed (this one was filed Dec 11, 2017) | Apr 9, 2035 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +34 days, USPTO patent term adjustment record | May 13, 2035 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,513,690, US 10,829,740, US 11,077,147, US 11,471,559, US 9,675,643, US 9,675,644, US 9,687,511) | capped to Apr 9, 2035 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 9, 2035 | High confidence |
This family
| Application 62/129,351 | Provisional application no patent term | no patent term |
| US 9,687,511 | In force Apr 2035 | Apr 2035 |
| US 9,675,643 | In force Apr 2035 | Apr 2035 |
| US 9,675,644 | In force Apr 2035 | Apr 2035 |
| Application 15/590,444 | Abandoned not computed | not computed |
| US 10,760,058 | In force Apr 2035 | Apr 2035 |
| US 10,513,690 | In force Apr 2035 | Apr 2035 |
| US 11,160,904 | this patent Apr 2035 | Apr 2035 |
8 of 12 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 12, 2017 Reel 44368, frame 674 | Ganey, Timothy; Namin, Shabnam; Sicard, Renaud; Weston, Wendy W | Vivex Biomedical, Inc. | Assignment of Assignor's Interest |
| Mar 19, 2019 Reel 48629, frame 691 | Vivex Biomedical, Inc.; Umtb Biomedical, Inc.; Advanced Numed Technologies, Ltd.; Vivex Biomedical International, Inc. | Heritage Bank of Commerce | Security Interest |
| Aug 16, 2019 Reel 50079, frame 179 | Vivex Biomedical, Inc. | Vivex Biologics, Inc. | Change of Name |
| Aug 16, 2019 Reel 50079, frame 225 | Vivex Biologics, Inc. | Vivex Biologics Group, Inc. | Change of Name |
| Dec 11, 2019 Reel 51260, frame 64 | Vivex Biologics Group, Inc. | Bankunited, N.a. | Notice of Grant of Security Interest in Patents |
| Dec 12, 2019 Reel 51282, frame 653 | Heritage Bank of Commerce | Vivex Biomedical, Inc.; Umtb Biomedical, Inc.; Advanced Numed Technologies, Ltd.; Vivex Biomedical International, Inc. | Release of Security Interest |
| Dec 12, 2019 reel/frame not recorded | Heritage Bank of Commerce | Vivex Biomedical, Inc. | Release of Security Interest |
| Dec 12, 2019 reel/frame not recorded | Heritage Bank of Commerce | Umtb Biomedical, Inc. | Release of Security Interest |
| Dec 12, 2019 reel/frame not recorded | Heritage Bank of Commerce | Advanced Numed Technologies, Ltd. | Release of Security Interest |
| Dec 12, 2019 reel/frame not recorded | Heritage Bank of Commerce | Vivex Biomedical International, Inc. | Release of Security Interest |
| Aug 4, 2022 Reel 61084, frame 607 | Vivex Biologics Group, Inc. | Heritage Bank of Commerce | Security Interest |
| Aug 29, 2022 Reel 61333, frame 853 | Bankunited, N.a. | Vivex Biologics Group, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Apr 2035
Term ends Apr 9, 2035. Maintenance fees still fall due before then
Note
The 34 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,513,690, US 10,829,740, US 11,077,147, US 11,471,559, US 9,675,643, US 9,675,644, US 9,687,511.
Citations
15
later US patents cite this one
That is top 10% of utility patents granted in 2021 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.